Stock comparison
Harmony Biosciences Holdings
HRMY
Market cap
$1.75B
Sector
Healthcare
Overall winner
Insulet
HRMY 2–4 PODD
Insulet
PODD
Market cap
$10.65B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
HRMYvsPODD
67B
61C
60C
87A
75B
78B
62C
62C
28F
52C
62C
64C
67B
65B
Side-by-side metrics
| Metric | HRMY | PODD |
|---|---|---|
| Market cap | $1.75B | $10.65B |
| P/E (TTM) | 11.8x | 36.2x |
| EV/EBIT | 6.4x | 23.9x |
| ROIC (TTM) | 12.5% | 16.39% |
| Gross margin | 76.55% | 71.01% |
| Net margin | 16.2% | 10.44% |
| Revenue CAGR 5y | 29.85% | 25.3% |
| EPS CAGR 5y | 46.45% | 93.57% |
| Debt / Equity | 0.2x | 0.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
- EV/EBIT6.4xvs 23.9x+73%
- Debt / Equity0.2xvs 0.7x+69%
- P/E (TTM)11.8xvs 36.2x+67%
- Net margin16.2%vs 10.44%+36%
PODD leads on
- Market cap$10.65Bvs $1.75B+84%
- EPS CAGR 5y93.57%vs 46.45%+50%
- ROIC (TTM)16.39%vs 12.5%+24%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.